Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma

Anticancer Research

Volumn 33, Issue 5, 2013, Pages 2029-2035

  Ahn, Eun Hyun ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; Growth suppression; PAX3 FOXO1; Rabdomyosarcoma

Indexed keywords

CYCLOHEXIMIDE; DEATH ASSOCIATED PROTEIN KINASE 1; GREMLIN 1 PROTEIN; HAIRY AND ENHANCER OF SPLIT RELATED WITH YRPW MOTIF 1 PROTEIN; MYOGENIC DIFFERENTIATION 1 PROTEIN; ONCOPROTEIN; PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REGULATORY MECHANISM; RHABDOMYOSARCOMA; UPREGULATION;

GENE EXPRESSION; GROWTH SUPPRESSION; PAX3-FOXO1; RABDOMYOSARCOMA;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MYOD PROTEIN; NIH 3T3 CELLS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA, ALVEOLAR; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84878197627     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Linardic CM: PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett 270: 10-18, 2008.
2. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ and Barr FG: PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: A Report from the Children's Oncology Group. J Clin Oncol 20: 2672-2679, 2002. (Pubitemid 34575640)
3. Stevens MC: Treatment for childhood rhabdomyosarcoma: The cost of cure. Lancet Oncol 6: 77-84, 2005.
4. Scrable HJ, Witte DP, Lampkin BC and Cavenee WK: Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 329: 645-647, 1987. (Pubitemid 17140118)
5. Visser M, Sijmons C, Bras J, Arceci RJ, Godfried M, Valentijn LJ, Voute PA and Baas F: Allelotype of pediatric rhabdomyosarcoma. Oncogene 15: 1309-1314, 1997. (Pubitemid 27429747)
6. Davis RJ and Barr FG: Fusion genes resulting from alternative chromosomal translocations are over-expressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc Natl Acad Sci USA 94: 8047-8051, 1997. (Pubitemid 27343774)
7. Anderson J, Gordon T, McManus A, Mapp T, Gould S, Kelsey A, McDowell H, Pinkerton R, Shipley J and Pritchard-Jones K: UK Children's Cancer Study Group (UKCCSG) and the UK Cancer Cytogenetics Group. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: A reproducible predictor of outcome? Br J Cancer 85: 831-835, 2001. (Pubitemid 33010549)
8. Kelly KM, Womer RB, Sorensen PHB, Xiong QB and Barr FG: Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 15: 1831-1836, 1997. (Pubitemid 27209511)
9. Khan J, Bittner ML, Saal LH, Teichmann U, Azorsa DO, Gooden GC, Pavan WJ, Trent JM and Meltzer PS: cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci USA 96: 13264-13269, 1999.
10. Wachtel M, Dettling M, Koscielniak E, Stegmaier S, Treuner J, Simon-Klingenstein K, Bühlmann P, Niggli FK and Schäfer BW: Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2:2)(q35;q23) translocation fusing PAX3 to NCOA1. Cancer Res 64: 5539-5545, 2004. (Pubitemid 39095545)
11. Wachtel M, Runge T, Leuschner I, Stegmaier S, Koscielniak E, Treuner J, Odermatt B, Behnke S, Niggli FK and Schäfer BW: Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. J Clin Oncol 24: 816-822, 2006. (Pubitemid 46622049)
12. Davicioni E, Finckenstein FG, Shahbazian V, Buckley JD, Triche TJ and Anderson MJ: Identification of a PAX-FKHR signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcoma. Cancer Res 66: 6936-6946, 2006. (Pubitemid 44197668)
13. De Pittà C, Tombolan L, Albiero G, Sartori F, Romualdi C, Jurman G, Carli M, Furlanello C, Lanfranchi G and Rosolen A: Gene expression profiling identifies potential relevant genes in alveolar rhabdomyosarcoma pathogenesis and discriminates PAX3-FKHR-positive and -negative tumors. Int J Cancer 118: 2772-27781, 2006.
14. Lae M, Ahn EH, Mercado GE, Chuai S, Edgar M, Pawel BR, Olshen A, Barr FG and Ladanyi M: Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FOXO1 fusion-negative embryonal rhabdomyosarcomas. J Pathol 212: 143-151, 2007. (Pubitemid 46852092)
15. Mercado GE, Xia SJ, Zhang C, Ahn EH, Strzelecki DM, Laé M, Ladanyi M and Barr FG: Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: Focus on MYCN as a biologically relevant target. Genes Chromosomes Cancer 47: 510-520, 2008. (Pubitemid 351657186)
16. Barr FG, Smith LM, Lynch JC, Strzelecki D, Parham DM, Qualman SJ and Breitfeld PP: Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: A report from the Children's Oncology Group. J Mol Diagn 8: 202-208, 2006. (Pubitemid 43811243)
17. Bennicelli JL, Edwards RH and Barr FG: Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Proc Natl Acad Sci USA 93: 5455-5459, 1996. (Pubitemid 26159471)
18. Tomescu O, Xia SJ, Strezlecki D, Bennicelli JL, Ginsberg J, Pawel B and Barr FG: Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression. Lab Invest 84: 1060-1070, 2004. (Pubitemid 39025040)
19. Xia SJ and Barr FG: Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein. Oncogene 23: 6864-6871, 2004. (Pubitemid 39279987)
20. Xia SJ, Rajput P, Strzelecki DM and Barr FG: Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoprotein. Lab Invest 87: 318-325, 2007. (Pubitemid 46474564)
21. Littlewood TD, Hancock DC, Danielian PS, Parker MG and Evan GI: A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 23: 1686-1690, 1995.
22. Ahn EH and Schroeder JJ: Sphinganine causes early activation of JNK and p38 and inhibition of AKT in HT-29 human colon cancer cells. Anticancer Res 26: 121-128, 2006.
23. Naini S, Etheridge KT, Adam SJ, Qualman SJ, Bentley RC, Counter CM and Linardic CM: Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma. Cancer Res 68: 9583-9588, 2008.
24. Xia SJ, Holder DD, Pawel BR, Zhang C and Barr FG: High expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblasts. Am J Pathol 175: 2600-2608, 2009.
25. Desai KV, Xiao N, Wang W, Gangi L, Greene J, Powell JI, Dickson R, Furth P, Hunter K, Kucherlapati R, Simon R, Liu ET and Green JE: Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc Natl Acad Sci USA 99: 6967-6972, 2002. (Pubitemid 34526241)
26. Cao L, Yu Y, Bilke S, Walker RL, Mayeenuddin LH, Azorsa DO, Yang F, Pineda M, Helman LJ and Meltzer PS: Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res 70: 6497-6508, 2010.
27. Sun J, Kamei CN, Layne MD, Jain MK, Liao JK, Lee ME and Chin MT: Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2. J Biol Chem 276: 18591-18596, 2001.
28. Buas MF, Kabak S and Kadesch T: Inhibition of myogenesis by Notch: Evidence for multiple pathways. J Cell Physiol 218: 84-93, 2009.
29. Tonin PN, Scrable H, Shimada H and Cavenee WK: Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. Cancer Res 51: 5100-5106, 1991.
30. Tapscott SJ, Thayer MJ and Weintraub H: Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 59: 1450-1453, 1993. (Pubitemid 23101380)
31. Ren YX, Finckenstein FG, Abdueva DA, Shahbazian V, Chung B, Weinberg KI, Triche TJ, Shimada H and Anderson MJ: Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Cancer Res 68: 6587-6597, 2008.
32. Graf Finckenstein F, Shahbazian V, Davicioni E, Ren YX and Anderson MJ: PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis. Oncogene 27: 2004-2014, 2008. (Pubitemid 351442734)
33. Epstein JA, Lam P, Jepeal L, Maas RL and Shapiro DN: Pax3 inhibits myogenic differentiation of cultured myoblast cells. J Biol Chem 270: 11719-11722, 1995.
34. Ebauer M, Wachtel M, Niggli FK and Schafer BW: Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR. Oncogene 26: 7267-7281, 2007. (Pubitemid 350085317)
35. Kikuchi K, Tsuchiya K, Otabe O, Gotoh T, Tamura S, Katsumi Y, Yagyu S, Tsubai-Shimizu S, Miyachi M, Iehara T and Hosoi H: Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma. Biochem Biophys Res Commun 365: 568-574, 2008. (Pubitemid 350181685)
36. Collins MH, Zhao H, Womer RB and Barr FG: Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: A comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions. Med Pediatr Oncol 37: 83-89, 2001. (Pubitemid 32738067)
37. Anderson J, Ramsay A, Gould S and Pritchard-Jones K: PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma. Am J Pathol 159: 1089-1096, 2001. (Pubitemid 32847199)
38. Bernasconi M, Remppis A, Fredericks WJ, Rauscher FJ 3rd and Schäfer BW: Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc Natl Acad Sci USA 93: 13164-13169, 1996. (Pubitemid 26382787)
39. Ayyanathan K, Fredericks WJ, Berking C, Herlyn M, Balakrishnan C, Gunther E and Rauscher FJ 3rd: Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene. Cancer Res 60: 5803-5814, 2000.
40. Ahn EH, Mercado GE, Laé M and Ladanyi M: Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma. Oncology Reports. In press 2013.